Russell Investments Group
VIR icon

Russell Investments Group’s Vir Biotechnology VIR Stock Holding History

Russell Investments Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$837K Sell
82,159
-54
-0.1% -$514 ﹤0.01% 2546
2026
Q1 		$737K Buy
82,213
+74,713
+996% +$595K ﹤0.01% 2356
2025
Q4 		$45.2K Sell
7,500
-22,127
-75% -$132K ﹤0.01% 3337
2025
Q3 		$169K Sell
29,627
-42,254
-59% -$216K ﹤0.01% 2864
2025
Q2 		$362K Buy
71,881
+7,042
+11% +$37.8K ﹤0.01% 2463
2025
Q1 		$420K Buy
64,839
+61,079
+1,624% +$543K ﹤0.01% 2357
2024
Q4 		$27.6K Sell
3,760
-16,839
-82% -$133K ﹤0.01% 2951
2024
Q3 		$154K Sell
20,599
-3,769
-15% -$32.7K ﹤0.01% 2567
2024
Q2 		$217K Sell
24,368
-1,603
-6% -$15.4K ﹤0.01% 2462
2024
Q1 		$263K Buy
25,971
+13,981
+117% +$142K ﹤0.01% 2383
2023
Q4 		$121K Sell
11,990
-13,654
-53% -$125K ﹤0.01% 2526
2023
Q3 		$240K Buy
25,644
+24,907
+3,380% +$355K ﹤0.01% 2451
2023
Q2 		$18.1K Sell
737
-1,963
-73% -$49.3K ﹤0.01% 2858
2023
Q1 		$62.8K Sell
2,700
-16,300
-86% -$417K ﹤0.01% 2678
2022
Q4 		$481K Buy
19,000
+9,169
+93% +$225K ﹤0.01% 2303
2022
Q3 		$186K Buy
9,831
+2,800
+40% +$71.2K ﹤0.01% 2557
2022
Q2 		$181K Sell
7,031
-37,638
-84% -$879K ﹤0.01% 2561
2022
Q1 		$1.15M Buy
44,669
+22,127
+98% +$656K ﹤0.01% 1892
2021
Q4 		$942K Buy
22,542
+16,691
+285% +$654K ﹤0.01% 2179
2021
Q3 		$253K Sell
5,851
-21,144
-78% -$915K ﹤0.01% 2700
2021
Q2 		$1.27M Sell
26,995
-10,635
-28% -$484K ﹤0.01% 2188
2021
Q1 		$1.93M Sell
37,630
-8,574
-19% -$462K ﹤0.01% 1891
2020
Q4 		$1.24M Buy
46,204
+12,234
+36% +$398K ﹤0.01% 2020
2020
Q3 		$1.17M Buy
33,970
+5,890
+21% +$254K ﹤0.01% 1996
2020
Q2 		$1.15M Buy
+28,080
New +$942K ﹤0.01% 1974

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Russell Investments Group's VIR Position: Q2 2026 in Review

Russell Investments Group reduced its Vir Biotechnology (VIR) stake by 0.07% in Q2 2026, selling an estimated $514 and leaving 82,159 shares worth $837K. The position accounts for ﹤0.01% of the portfolio, ranked #2546.

Russell Investments Group first reported a position in VIR in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.93M in Q1 2021. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Russell Investments Group held 82,159 shares of Vir Biotechnology worth $837K as of Q2 2026.
  • Russell Investments Group sold 54 Vir Biotechnology shares in Q2 2026, an estimated $514.
  • Vir Biotechnology made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2546 holding.
  • Russell Investments Group first reported a position in Vir Biotechnology in Q2 2020 and has held it in 25 quarters since.
  • Russell Investments Group's Vir Biotechnology position peaked at $1.93M in Q1 2021.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.